- cafead   Mar 15, 2023 at 10:32: AM
via Weeks after the FDA rejected Veru’s Emergency Use Authorization (EUA) bid for sabizabulin in COVID-19, the company announced plans to continue with late-stage development of the drug.
article source
article source